Episode
Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
- Podcast
- Gynecologic Oncology Update
- Published
- Dec 20, 2023
- Duration seconds
- 3936
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/oncology-today-with-dr-neil-love-role-of-her2-directed-therapy-in-the-treatment-of-her2-expressing-gynecologic-cancers-part-1-of-a-special-3-part-edition/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/gynecologic-oncology-update-612940/oncology-today-with-dr-neil-love-role-of-her2-directed-therapy-in-the-treatment-of-her2-expressing-gynecologic-cancers-part-1-of-a-special-3-part-edition.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers.